Adial Pharmaceuticals has announced the issuance of patent number 12,226,401, which enhances their genetic-based approach for treating alcohol and opioid use disorders. This new patent focuses on ...
Naltrexone has long been used to treat alcohol use disorder. Now it’s gaining attention as a tool for people who want to cut ...
Jesse Richards, director of Obesity Medicine and assistant professor of Medicine at OU-TU School of Community Medicine and lead author of the study. The first published evidence from humans that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback